폴리머 나노입자 시장 예측(-2030년) : 유형별, 폴리머 유형별, 용도별, 최종사용자별, 지역별 세계 분석

According to Stratistics MRC, the Global Polymeric Nanoparticles Market is accounted for $784.25 million in 2024 and is expected to reach $1575.92 million by 2030 growing at a CAGR of 12.5% during the forecast period. Polymeric nanoparticles are tiny, biocompatible, and biodegradable particles ranging from 10 to 1000 nm in size, composed of natural or synthetic polymers. They serve as carriers for drugs, genes, or biomolecules, enhancing stability, controlled release, and targeted delivery. Their applications span medicine, pharmaceuticals, and biotechnology, improving drug solubility, bioavailability, and therapeutic efficiency.

According to a study report by the National Library of Medicines in 2023 revealed that nanotechnology may efficiently treat over 50% of CVDs.

Market Dynamics:

Driver:

Growing demand for targeted drug delivery

Polymeric nanoparticles enable controlled and site-specific drug release, making them ideal for treating chronic diseases like cancer, cardiovascular disorders, and neurological conditions. Their ability to protect drugs from degradation and enhance bioavailability increases their adoption in pharmaceuticals. Additionally, the rising prevalence of diseases and increasing R&D in nanotechnology further drive the development and commercialization of polymeric nanoparticle-based drug delivery systems.

Restraint:

Potential toxicity issues

Polymeric nanoparticles pose potential toxicity issues due to their small size, surface reactivity, and possible bioaccumulation in tissues, leading to unforeseen health and environmental risks. Their prolonged exposure may cause cellular damage, inflammation, or immune system responses. Stricter testing requirements and cautious consumer perception further delay commercialization, increasing costs and reducing investor confidence, thereby hampering overall market growth.

Opportunity:

Increasing investments in nanomedicine

Funding from governments, pharmaceutical companies, and research institutions enables the development of novel polymeric nanoparticle formulations for targeted drug delivery, gene therapy, and cancer treatment. These investments support clinical trials, regulatory approvals, and large-scale production, making polymeric nanoparticles more accessible for medical applications. As a result, expanding nanomedicine funding directly fuels the demand and adoption of polymeric nanoparticles.

Threat:

Complex synthesis & scalability challenges

Polymeric nanoparticles face complex synthesis and scalability challenges due to precise formulation requirements, intricate polymer selection, and the need for controlled size, stability, and drug-loading efficiency. Advanced techniques like emulsion polymerization and nanoprecipitation require strict process control, making large-scale production difficult and expensive. These challenges hinder mass production, increase costs, and limit widespread adoption, especially in developing markets.

Covid-19 Impact:

The covid-19 pandemic significantly impacted the polymeric nanoparticles market, both positively and negatively. Disruptions in the global supply chain initially slowed production and raw material availability. However, increased demand for nanocarrier-based drug delivery systems and vaccine development boosted market growth. Polymeric nanoparticles played a crucial role in mRNA vaccine delivery and targeted therapeutics. Post-pandemic, the market continues to expand, driven by biomedical advancements and sustained investment in nanotechnology.

The gene therapy segment is expected to be the largest during the forecast period

The gene therapy segment is expected to account for the largest market share during the forecast period. Polymeric nanoparticles play a crucial role in gene therapy by enabling safe and efficient delivery of genetic material. These biodegradable and biocompatible carriers protect nucleic acids (DNA, RNA) from degradation, enhance cellular uptake, and enable controlled release. PNPs reduce immune responses and improve gene transfection efficiency compared to viral vectors.

The cosmetics & personal care segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cosmetics & personal care segment is predicted to witness the highest growth rate, owing to its enhanced product efficacy, stability, and skin penetration. They are used in skincare, haircare, and sunscreens for controlled ingredient release, prolonged effects, and improved bioavailability. PNPs protect sensitive active ingredients like vitamins, antioxidants, and UV filters from degradation. Their small size enables deeper skin absorption, enhancing hydration and anti-aging benefits.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to increasing demand in pharmaceuticals, drug delivery, cosmetics, and food packaging. Countries like China, India, and Japan are leading the market, driven by expanding healthcare infrastructure, rising R&D investments, and technological advancements. Additionally, government support for nanotechnology research and sustainable packaging solutions contributes to market expansion.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by advancements in nanotechnology, increasing applications in drug delivery, and rising demand in healthcare, electronics, and food packaging industries. The U.S. leads the market with strong R&D investments and pharmaceutical innovations. Government funding and collaborations between biotech firms and research institutions further fuels the region's growth.

Key players in the market

Some of the key players in Polymeric Nanoparticles market include Arkema, BASF SE, Aphios Corporation, Cabot Corporation, CD Bioparticles, Liquidia Technologies, Hybrid Plastics Inc., Nanorh, Precision NanoSystems Inc., Sigma-Aldrich, Bruker, Nanoform, Fortis Life Sciences, Nanotherapeutics Inc., Spectradyne, Revalesio Corporation, Cerulean Pharma Inc. and Alnylam Pharmaceuticals.

Key Developments:

In December 2024, BASF inaugurated its new Catalyst Development and Solids Processing Center in Ludwigshafen, Germany. This state-of-the-art research facility serves as a hub for pilot-scale synthesis of chemical catalysts and the development of new solids processing technologies. The center aims to accelerate the transition from laboratory-scale innovations to production-ready solutions, providing global customers with faster access to advanced technologies.

In May 2024, Arkema introduced the peroxide-cured resin compositions that maintain extended open times at ambient temperatures while achieving rapid cure times when exposed to elevated temperatures. This development signifies Arkema's commitment to advancing materials science, offering solutions that improve both the performance and processing efficiency of resin-based composite materials.

Types Covered:

• Nanocapsules
• Nanospheres

Polymer Types Covered:

• Natural Polymers
• Synthetic Polymers

Applications Covered:

• Drug Delivery
• Cancer Therapy
• Vaccine Delivery
• Diagnostics & Imaging
• Tissue Engineering & Regenerative Medicine
• Gene Therapy
• Other Applications

End Users Covered:

• Pharmaceuticals & Biotechnology
• Cosmetics & Personal Care
• Food & Beverages
• Agriculture & Pesticides
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Polymeric Nanoparticles Market, By Type

• 5.1 Introduction
• 5.2 Nanocapsules
• 5.3 Nanospheres

6 Global Polymeric Nanoparticles Market, By Polymer Type

• 6.1 Introduction
• 6.2 Natural Polymers
  • 6.2.1 Chitosan
  • 6.2.2 Cellulose
  • 6.2.3 Gelatin
  • 6.2.4 Alginate
• 6.3 Synthetic Polymers
  • 6.3.1 Polylactic Acid (PLA)
  • 6.3.2 Poly(lactic-co-glycolic acid) (PLGA)
  • 6.3.3 Polycaprolactone (PCL)
  • 6.3.4 Polyethylene Glycol (PEG)
  • 6.3.5 Polyacrylamide

7 Global Polymeric Nanoparticles Market, By Application

• 7.1 Introduction
• 7.2 Drug Delivery
• 7.3 Cancer Therapy
• 7.4 Vaccine Delivery
• 7.5 Diagnostics & Imaging
• 7.6 Tissue Engineering & Regenerative Medicine
• 7.7 Gene Therapy
• 7.8 Other Applications

8 Global Polymeric Nanoparticles Market, By End User

• 8.1 Introduction
• 8.2 Pharmaceuticals & Biotechnology
• 8.3 Cosmetics & Personal Care
• 8.4 Food & Beverages
• 8.5 Agriculture & Pesticides
• 8.6 Other End Users

9 Global Polymeric Nanoparticles Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.9 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.9 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.9 Middle East & Africa
  • 9.9.1 Saudi Arabia
  • 9.9.2 UAE
  • 9.9.3 Qatar
  • 9.9.4 South Africa
  • 9.9.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Arkema
• 11.2 BASF SE
• 11.3 Aphios Corporation
• 11.4 Cabot Corporation
• 11.5 CD Bioparticles
• 11.6 Liquidia Technologies
• 11.7 Hybrid Plastics Inc.
• 11.8 Nanorh
• 11.9 Precision NanoSystems Inc.
• 11.10 Sigma-Aldrich
• 11.11 Bruker
• 11.12 Nanoform
• 11.13 Fortis Life Sciences
• 11.14 Nanotherapeutics Inc.
• 11.15 Spectradyne
• 11.16 Revalesio Corporation
• 11.17 Cerulean Pharma Inc.
• 11.18 Alnylam Pharmaceuticals